Next Article in Journal
EphA2-Receptor Targeted PEGylated Nanoliposomes for the Treatment of BRAFV600E Mutated Parent- and Vemurafenib-Resistant Melanoma
Next Article in Special Issue
Pharmaceutical Benefits of Fluticasone Propionate Association to Delivery Systems: In Vitro and In Vivo Evaluation
Previous Article in Journal
Injectable Thermosensitive Formulation Based on Polyurethane Hydrogel/Mesoporous Glasses for Sustained Co-Delivery of Functional Ions and Drugs
Previous Article in Special Issue
Aerosolization Performance of Jet Nebulizers and Biopharmaceutical Aspects
 
 
Article

Article Versions Notes

Pharmaceutics 2019, 11(10), 502; https://doi.org/10.3390/pharmaceutics11100502
Action Date Notes Link
article xml file uploaded 1 October 2019 10:51 CEST Original file -
article xml uploaded. 1 October 2019 10:51 CEST Update -
article pdf uploaded. 1 October 2019 10:51 CEST Version of Record https://www.mdpi.com/1999-4923/11/10/502/pdf-vor
article html file updated 1 October 2019 10:53 CEST Original file -
article xml file uploaded 16 October 2019 06:42 CEST Update -
article xml uploaded. 16 October 2019 06:42 CEST Update https://www.mdpi.com/1999-4923/11/10/502/xml
article pdf uploaded. 16 October 2019 06:42 CEST Updated version of record https://www.mdpi.com/1999-4923/11/10/502/pdf
article html file updated 16 October 2019 06:44 CEST Update -
article html file updated 30 October 2019 22:10 CET Update -
article html file updated 13 February 2020 21:47 CET Update -
article html file updated 20 July 2022 02:22 CEST Update https://www.mdpi.com/1999-4923/11/10/502/html
Back to TopTop